Toxoplasma gondii is an intracellular protozoan parasite that causes a Th1 cellular immunity. Our previous study showed that T. gondii lysate antigen (TLA) treatment in S180 tumor-bearing mice resulted in tumor reduction by suppressing CD31 expression, a marker of angiogenesis. In the present study, to investigate tumor suppressive effect of TLA under the absence of T lymphocytes, athymic nude mice were compared with euthymic mice in the anti-tumorigenic effect triggered by TLA in CT26 tumors. According to the results, intratumorally injected TLA reduced tumor growth and TIMP-1 level, a metastatic marker, in both euthymic and athymic mice. TLA treatment led to a sharp increase in IL-12 expression in serum cytokine profiling of athymic mice, and increased MyD88 signals in macrophages derived from the bone marrow, implying the activation of innate immunity. The selective induction of IL-12 by TLA treatment had an anti-tumorigenic effect.
Citations
Citations to this article as recorded by
An Overview of the Dichotomous Role of Microbiota in Cancer Progression and Management Pooja Jain, Sradhanjali Mohapatra, Uzma Farooq, Nazia Hassan, Mohd. Aamir Mirza, Zeenat Iqbal Current Cancer Drug Targets.2025; 25(1): 38. CrossRef
Bug as a drug: Unveiling anti-cancer properties of Toxoplasma gondii and its therapeutic prospects in cancer immunotherapy Yie Wei Chua, Sek Chuen Chow Acta Tropica.2025; 267: 107684. CrossRef
From pathogen to cure: exploring the antitumor potential of Toxoplasma gondii Parisa Alipanahi, Arezou Khosrojerdi, Abdol Satar Pagheh, Kareem Hatam-Nahavandi, Ehsan Ahmadpour Infectious Agents and Cancer.2025;[Epub] CrossRef
Bridging the gap for diverse applications of parasites as advanced cancer therapeutics: current progress and future directions Maha M. Eissa, Marwa H. El-Faham, Nahla El Skhawy Infectious Agents and Cancer.2025;[Epub] CrossRef
Evaluation of Antitumor Effects of Toxoplasma gondii Different Antigens on Ehrlich Solid Carcinoma in Mice Salwa S. Younis, Basma M. Elmansory, Hend A. Elrefaey, Nahla A. Nasef, Sara H. Elakshar, Radwa A. Awad, Ghada A. Gamea Parasite Immunology.2025;[Epub] CrossRef
A novel enemy of cancer: recent investigations into protozoan anti-tumor properties Zhi Zheng, Xiao Lu, Dong Zhou, Xu-feng Deng, Quan-xing Liu, Xiao-bing Liu, Jiao Zhang, Yan-qi Li, Hong Zheng, Ji-gang Dai Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
Parasite-enhanced immunotherapy: transforming the “cold” tumors to “hot” battlefields Yujun Xie, Jinyan Wang, Yafei Wang, Yalin Wen, Yanping Pu, Benfan Wang Cell Communication and Signaling.2024;[Epub] CrossRef
Parasites revive hope for cancer therapy Maha M. Eissa, Ahmed Ebada Salem, Nahla El Skhawy European Journal of Medical Research.2024;[Epub] CrossRef
Toxoplasma gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma gondii Lai-Xi Zhao, Qiong Sun, Chong Wang, Jia-Jia Liu, Xiao-Rong Yan, Meng-Ci Shao, Li Yu, Wen-Hua Xu, Rui Xu International Journal of Nanomedicine.2024; Volume 19: 12421. CrossRef
Association of Neuroblastoma (NB) SH-SY5Y Cells with Antibodies of Parasitic Origin (Anti-Acanthamoeba and Anti-Toxocara canis) Víctor Alberto Maravelez Acosta, Maria de Lourdes Caballero Garcia, Genaro Patiño López, María del Pilar Crisóstomo Vázquez, Luz Ofelia Franco Sandoval, Leticia Eligio García International Journal of Molecular Sciences.2024; 25(24): 13577. CrossRef
Promising effects of parasite-derived compounds on tumor regression: a systematic review of in vitro and in vivo studies Ali Asghari, Hassan Nourmohammadi, Hamidreza Majidiani, Seyyed Ali Shariatzadeh, Davood Anvari, Sadegh Shamsinia, Ezatollah Ghasemi, Morteza Shams, Gholam Basati Environmental Science and Pollution Research.2022; 29(22): 32383. CrossRef
Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth Jiating Chen, Wenzhong Liao, HongJuan Peng Frontiers in Cellular and Infection Microbiology.2022;[Epub] CrossRef
Neospora caninum inhibits tumor development by activating the immune response and destroying tumor cells in a B16F10 melanoma model Xiaojin Li, Meng Qi, Kai He, Haiyan Liu, Wenlan Yan, Lizhuo Zhao, Yanyan Jia, Lei He, Chaochao Lv, Min Zhang, Zhiguo Wei, Wenchao Yan, Tianqi Wang, Fuchang Yu, Weifeng Qian Parasites & Vectors.2022;[Epub] CrossRef
Exploiting the Macrophage Production of IL-12 in Improvement of Vaccine Development against Toxoplasma gondii and Neospora caninum Infections Ragab M. Fereig, Mosaab A. Omar, Abdullah F. Alsayeqh Vaccines.2022; 10(12): 2082. CrossRef
Toxoplasma GRA16 Inhibits NF-κB Activation through PP2A-B55 Upregulation in Non-Small-Cell Lung Carcinoma Cells Seung-Hwan Seo, Sang-Gyun Kim, Ji-Hun Shin, Do-Won Ham, Eun-Hee Shin International Journal of Molecular Sciences.2020; 21(18): 6642. CrossRef
Increase in the nuclear localization of PTEN by the Toxoplasma GRA16 protein and subsequent induction of p53‐dependent apoptosis and anticancer effect Sang‐Gyun Kim, Seung‐Hwan Seo, Ji‐Hun Shin, Jung‐Pyo Yang, Sang Hyung Lee, Eun‐Hee Shin Journal of Cellular and Molecular Medicine.2019; 23(5): 3234. CrossRef
Characteristics of Infection Immunity Regulated by Toxoplasma gondii to Maintain Chronic Infection in the Brain Young Sang Hwang, Ji-Hun Shin, Jung-Pyo Yang, Bong-Kwang Jung, Sang Hyung Lee, Eun-Hee Shin Frontiers in Immunology.2018;[Epub] CrossRef
Microorganisms in the Treatment of Cancer: Advantages and Limitations Klaudia Łukasiewicz, Marek Fol Journal of Immunology Research.2018; 2018: 1. CrossRef
The Neurotropic Parasite Toxoplasma gondii Induces Sustained Neuroinflammation with Microvascular Dysfunction in Infected Mice Vanessa Estato, Joice Stipursky, Fabiana Gomes, Tally C. Mergener, Edwards Frazão-Teixeira, Silvana Allodi, Eduardo Tibiriçá, Helene S. Barbosa, Daniel Adesse The American Journal of Pathology.2018; 188(11): 2674. CrossRef
Puzzling and ambivalent roles of malarial infections in cancer development and progression ERIC FAURE Parasitology.2016; 143(14): 1811. CrossRef
NaHCO3 enhances the antitumor activities of cytokine-induced killer cells against hepatocellular carcinoma HepG2 cells Ya Hong Yuan, Chun Fang Zhou, Jiang Yuan, Li Liu, Xing Rong Guo, Xiao Li Wang, Yan Ding, Xiao Nan Wang, Dong Sheng Li, Han Jun Tu Oncology Letters.2016; 12(5): 3167. CrossRef
Immune adjuvant effect of aToxoplasma gondiiprofilin-like protein in autologous whole-tumor-cell vaccination in mice Kyoung-Ho Pyo, You-Won Lee, Sun Min Lim, Eun-Hee Shin Oncotarget.2016; 7(45): 74107. CrossRef